JW Shinyak Reports Operating Profit of 900 Million KRW in Q2, Down 14% Year-on-Year
[Asia Economy Reporter Geum Bo-ryeong] JW Pharmaceutical announced on the 31st that its operating profit for the second quarter of this year, based on separate standards, was tentatively estimated at 927 million KRW, down 13.9% from the previous year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
During the same period, sales amounted to 21.849 billion KRW, a decrease of 2.9%.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
